|
Observational Aspirin Use and CVD in the Physicians' Health Study Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Observational Aspirin Use and CVD in the Physicians' Health Study conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Observational Aspirin Use and CVD in the Physicians' Health Study Clinical research trials and Observational Aspirin Use and CVD in the Physicians' Health Study medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Observational Aspirin Use and CVD in the Physicians' Health Study. Observational Aspirin Use and CVD in the Physicians' Health Study Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Observational Aspirin Use and CVD in the Physicians' Health Study clinical trial. Subjects typically recieve the finest healthcare available for their Observational Aspirin Use and CVD in the Physicians' Health Study condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "O" Clinical Trials Conditions > Observational Aspirin Use and CVD in the Physicians' Health Study  Observational Aspirin Use and CVD in the Physicians' Health Study
Observational Aspirin Use and CVD in the Physicians' Health Study
For Condition: Heart Diseases,Cardiovascular Diseases,Cerebrovascular Accident,Myocardial Infarction,Coronary Disease
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To analyze existing data from the Physicians Health Study (PHS), a randomized primary prevention trial of low-dose aspirin and beta carotene conducted among 22,071 U.S. male physicians, to address questions concerning aspirin and cardiovascular (CV) disease that could not adequately be addressed during the randomized aspirin period.
Details: DESIGN NARRATIVE: The aspirin component of the trial was terminated on January 25, 1988, due to a demonstrated benefit of aspirin on myocardial infarction. At that time, however, the number of strokes and CV deaths experienced by trial participants was inadequate to definitively evaluate these endpoints. The beta carotene component of the trial continued uninterrupted until its scheduled termination in December, 1996. During this period detailed information continued to be collected on post-trial aspirin use through annual questionnaires. As of October, 1995, the number of deaths, including cardiovascular deaths, had increased fourfold from that in the randomized period, and the number of strokes had increased 3.5 times. The investigators used data from both the randomized aspirin period and the observational period following the trial to assess the impact of aspirin use on cardiovascular and total mortality, and the long-term impact of aspirin use on subsequent stroke and MI. The methods included analyses of both randomized aspirin assignment and of time-varying aspirin use, as assessed on the annual questionnaires. Because of the potential for bias, the propensity for aspirin use, particularly during the observational period was taken into account. Analyses included use of proportional hazards models allowing for both time-varying effects of aspirin use and controlling for time-varying confounders, as well as more complex procedures using causal modeling.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
NancyCook, , Brigham and Women's Hospital
Additional Information:
Study ID Numbers: 5010;
Study Start Date: April 1998
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005493
Other Myocardial Infarction Studies:
1. Bogalusa Heart Study
2. Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
3. Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
4. Coronary Disease Morbidity and Mortality in a Population
5. Epidemiology of Coronary Artery Calcification
Related Studies:
Other Myocardial Infarction Clinical Trials
Other Clinical Trials
Other Clinical Trials
Observational Aspirin Use and CVD in the Physicians' Health Study
|
|
|
|
|
|
|
|
